About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Novartis Sued for Paying Kickbacks

by Dr. Enozia Vakil on April 27, 2013 at 2:00 PM
Font : A-A+

 Novartis Sued for Paying Kickbacks

Novartis was found guilty of paying kickbacks to doctors to prescribe the company's drugs over rival products by the US Justice Department.

In the second US lawsuit against the Swiss firm this week, the Justice Department said its US unit Novartis Pharmaceuticals had boosted sales of its more expensive brand-name drugs by offering incentives to prescribing doctors that were ultimately paid for by public health care programs.

Advertisement

The lawsuit, filed in the US district court in New York, alleged that, to promote Novartis drugs like Lotrel and Valturna, used for hypertension, and Starlix, for diabetes, the company paid doctors to make speeches at what were only "social occasions" and put on lavish dinners for the doctors.

Such actions "were, in reality, kickbacks to the speakers and attendees to induce them to write prescriptions for Novartis drugs," the department said.
Advertisement

The payments violated the US Anti-Kickback Statute and led to the government paying "false claims" via its health-care programs for Novartis pharmaceutical products.

On Tuesday the government filed suit against Novartis for paying kickbacks to pharmacies to substitute its drug Myfortic for cheaper generic drugs used to help transplant patients.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Link between Dietary Intake of Plant-based Essential Fatty Acids and Death Risk
Aspirin may be Harmful When Used for Preventing 1st Heart Attack, Stroke
Pregnancy Complications Elevated Among Symptomatic COVID-19 Women
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug
Swiss pharmaceutical giants Novartis has received a huge blow to its Indian operations after the ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use